Intestinal permeability in cirrhotic patients with and without spontaneous bacterial peritonitis: Is the ring closed

American Journal of Gastroenterology

Volumn 105, Issue 2, 2010, Pages 323-327

  Scarpellini, Emidio ^a   Valenza, Venanzio ^a   Gabrielli, Maurizio ^a   Lauritano, Ernesto Cristiano ^a   Perotti, Germano ^a   Merra, Giuseppe ^a   Dal Lago, Antonio ^a   Ojetti, Veronica ^a   Ainora, Maria Elena ^a   Santoro, Michele ^a   Ghirlanda, Giovanni ^a   Gasbarrini, Antonio ^a  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EDETATE CHROMIUM CR 51;

ADULT; ARTICLE; ASCITES; ASCITES FLUID; BACTERIAL PERITONITIS; CONTROLLED STUDY; FEMALE; FUNCTION TEST; HUMAN; INTESTINE MUCOSA PERMEABILITY; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PARACENTESIS; PRIORITY JOURNAL; SPONTANEOUS BACTERIAL PERITONITIS;

ADULT; AGED; ASCITES; BACTERIAL TRANSLOCATION; CASE-CONTROL STUDIES; CHROMIUM RADIOISOTOPES; EDETIC ACID; FEMALE; HUMANS; INTESTINAL ABSORPTION; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PERITONITIS; PERMEABILITY; RISK FACTORS;

EID: 76349105495     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2009.558     Document Type: Article

References (28)

1. Guarner C, Soriano G. Bacterial translocation and its consequences in patients with cirrhosis. Eur J Gastroenterol Hepatol 2005; 17: 27-31.
2. Rasaratnam B, Connelly N, Chin-Dusting J. Nitric oxide and the hyper-dynamic circulation in cirrhosis: is there a role for selective intestinal decontamination? Clin Sci 2004; 107: 425-434
3. Wiest R, Garcia-Tsao G. Bacterial translocation (BT) in cirrhosis. Hepatology 2005; 41: 422-433
4. Rasaratnam B, Kaye D, Jennings G et al. Teefectofselectiveintestinal decontamination on the hyperdynamic circulatory state in cirrhosis. A randomized trial. Ann Intern Med 2003; 139: 186-193
5. Vaughan RB, Chin-Dusting JP. Current pharmacotherapy in the management of cirrhosis: focus on the hyperdynamic circulation. Expert Opin Pharmacother 2003; 4: 625-637
6. De Meo M T, Mutlu E A, Keshavarzian A et al. Intestinal permeation and gastrointestinal disease. J Clin Gastroenterol 2002;34:385-396
7. Balimane PV, Chong S, Morrison RA. Current methodologies used for the evaluation of the intestinal permeability and absorption. J Pharmacol Toxicol Methods 2000;44:301-312
8. Egan WJ, Lauri G. Prediction of intestinal permeability. Adv Drug Deliv Rev 2002;54:273-89.
9. Ramachandran A, Balasubramanian KA. Intestinal dysfunction in liver cirrhosis: its role in spontaneous bacterial peritonitis. J Gastroenterol Hepatol 2001;16:607-612
10. Zhang S, Wang W, Ren W et al. Efects of lactulose on intestinal endotoxin and bacterial translocation in cirrhotic rats. Chin Med J 2003; 116: 767-771 (Pubitemid 36701867)
11. Kruschewski M, Anderson T, Buhr H J et al. Selective COX-2 inhibition reduces leukocyte sticking and improves the microcirculation in TNBS colitis. Dig Dis Sci 2006;51:662-670
12. Reddy B S, Macfe J, Gatt M et al. Randomized clinical trial of ef ect of syn-biotics, neomycin and mechanical bowel preparation on intestinal barrier function in patients undergoing colectomy. Br J Surg 2007;94:546-554
13. Bjarnason I, Ward K, Peters T J. The leaky gut of alcoholism: possible route of entry for toxic compounds. Lancet 1984;1:179-182
14. Rossi M, Sganga G, Mazzone M et al. Cardiopulmonary bypass in man: role of the intestine in a self-limiting inf ammatory response with demonstrable bac terial translocation. Ann Torac Surg 2004;77:612-618
15. Aabakken L. 51Cr-ethylenediaminetetraacetic acid absorption test. Meth-odologic aspects. Scand J Gastroenterol 1989;24:351-358
16. Miele L, Valenza V, La Torre G et al. Increased intestinal permeability and tight junction alterations in non-alcoholic fatty liver disease. Hepatology 2009; 49: 1877-1887
17. Budillon G, Parrilli G, Pacella M et al. Investigation of intestine and liver function in cirrhosis using combined sugar loads. J Hepatol 1985; 1: 513-524
18. Bac D J, Swart R G, Van Den Berg JW O et al. Small bowel wall function in patients with advanced liver cirrhosis and portal hypertension: studies on permeability and luminal bacterial overgrowth. Eur J Gastroenterol Hepatol 1993;5:383-387
19. Huglo D, De Botton S, Canva-Delcambre V et al. Simultaneous determination of pulmonary and intestinal permeability in patients with alcoholic liver cirrhosis. Eur J Nucl Med 2001;28:1505-1511
20. Pascual S, Such J, Esteban A et al. Intestinal permeability is increased in patients with advanced cirrhosis. Hepatol Gastroenterol 2003; 50:1482-1486
21. Ersoz G, Aydin A, Erdem S et al. Intestinal permeability in liver cirrhosis. Eur J Gastroenterol Hepatol 1999;11:409-412
22. Campillo B, Pernet P, Bories PN et al. Intestinal permeability in liver cir-rhosis: relationship with severe septic complications. Eur J Gastroenterol Hepatol 1999;11:755-759
23. Fujii T, Seki T, Maruoka M et al. Lactulose-L-rhamnose intestinal perme-ability test in patients with liver cirrhosis. Hepatol Res 2001;19:158-169
24. Zuckerman MJ, Menzies IS, Path FRC et al. Assessment of intestinal permeability and absorption in cirrhotic patients with ascites using combined sugar probes. Dig Dis Sci 2004;49:621-626
25. Bjarnason I, MacPherson A, Hollander D. Intestinal permeability: an overview. Gastroenterology 1995;108:1566-1581
26. Gunnarsdottir S A, Sadik R, Shev S et al. Small intestinal motility disturbances and bacterial overgrowth in patients with liver cirrhosis and portal hypertension. Am J Gastroenterol 2003;98:1362-1370
27. Kalaitzakis E, Johansson J E, Bjarnason I et al. Intestinal permeability in cir-rhotic patients with and without ascites. Scand J Gastroenterol 2006; 41: 326-330
28. Pérez-Paramo M, Muñoz J, Albillos A et al. E f ect of propranolol on the factors promoting bacterial translocation in cirrhotic rats with ascites. Hepatology 2000; 31: 43-48